Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report
- PMID: 23041818
- PMCID: PMC3670420
- DOI: 10.1086/668023
Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report
Abstract
A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HO-CDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used.
Conflict of interest statement
Figures
References
-
- American Cancer Society. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/can....
-
- Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis. 1993;17(1):109–113. - PubMed
-
- Gorschluter M, Glasmacher A, Hahn C, et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis. 2001;33(6):786–791. - PubMed
-
- Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile–associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–2449. - PubMed
-
- Bobak D, Arfons LM, Creger RJ, Lazarus HM. Clostridium difficile–associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplantation. 2008;42(11):705–713. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
